A missed quarter is evidence, not a diagnosis. The postmortem usually starts with the wrong question: which rep, which deal, which excuse. The better question is which kind of miss it was, because each kind points somewhere different and calls for a different fix.

Most misses come from four causes. They look alike in the final number. They look very different in the pipeline, weeks before the quarter closes.

  1. 01The deal was never real.
  2. 02The deal was real, but the timing slipped.
  3. 03The buyer decided to do nothing.
  4. 04A competitor won.

The deal was never real.

It sat in the forecast because a rep believed it, not because the buyer had committed to anything. The tell is missing evidence: no confirmed decision process, no economic buyer met, a close date that moved but never firmed up. These deals were already visible in the CRM. The forecast just didn't ask for proof.

The deal was real, but the timing slipped.

The buyer still wants it, just not this quarter. Usually the rep never mapped the buyer's paper process: the security review, the legal review, purchasing wanting its pound of flesh, an operations lead or implementation PM who joins late with questions of their own. The details vary. The late-stage surprise doesn't. The tell is a close date that has been pushed more than once while the stage stays put. One slip is normal. Three slips on the same deal is a forecast problem dressed as a timing problem.

The buyer decided to do nothing.

No competitor won. The status quo did. Usually the rep was working too low in the organization, with a champion who didn't have the juice and was never really tested along the way. Sometimes the budget was never there, or nobody with the authority to move it from somewhere else would do so. The tell is a deal with activity but no urgency: meetings happen, and nobody can say what it costs the buyer to wait. Losses to no decision are usually a discovery problem, not a closing problem.

A competitor won.

This is the cause most teams reach for first and the one that is least often true. The tell is real: a named competitor, a late evaluation, a pricing conversation that came out of nowhere. When it is the cause, it usually traces back to how the deal was qualified and positioned, not how it was closed.

How to tell them apart before the quarter closes

Start with four hygiene checks on every open deal, every week: a close date in the past, no update in 30 days, no movement in 60, and a confidence level that doesn't fit the stage. They tell you a deal is drifting. They don't tell you why.

For that, look at who is on the deal and what the team actually knows about it. Late in the cycle, the contact list and the MEDDPICC fields point straight at the cause:

What you see on the dealCause
One contact on a late-stage deal, or a champion with no one above them1 3
No economic buyer met, or Economic buyer left blank1
A new buyer-side name in the last few weeks: security, legal, purchasing, implementation2
Decision process or Paper process blank, so the close date is the rep's guess2
Metrics or Identify pain blank, so nobody can say what waiting costs the buyer3
A Champion who has never been asked to do anything hard3
Competition marked "none" this late in the cycle4

The blanks matter as much as the answers. A field nobody filled in is a question nobody asked the buyer. You can only analyze as deep as what you capture in the CRM.

Why the cause matters more than the miss

Each of these four is a symptom. Behind it sits a gap in people, process, data or systems: a rep who wasn't coached on qualification, a stage definition nobody enforces, a field nobody fills in, a report nobody runs. Fix the deal and you save a quarter. Fix what produced it and you stop repeating the miss.

That is the work: read the evidence, rank what is holding the number back, and decide what to fix first.

Find your line.